Singapore markets close in 2 hours 51 minutes

HCW Biologics Inc. (HCWB)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
1.0000-0.0300 (-2.91%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
3,927
2,842
6,722
0
4,100
-
Cost of revenue
2,764
2,281
4,136
0
-
-
Gross profit
1,163
560.36
2,586
0
-
-
Operating expenses
Research development
7,544
7,676
9,338
8,174
7,255
-
Selling general and administrative
15,954
13,084
7,988
4,976
2,436
-
Total operating expenses
29,013
26,278
17,665
13,368
9,924
-
Operating income or loss
-27,850
-25,717
-15,079
-13,368
-5,825
-
Interest expense
189.604
283.042
126.66
0
-
-
Total other income/expenses net
648.205
1,006
304.735
505.366
-
-
Income before tax
-27,392
-24,994
-14,901
-12,862
-5,802
-
Income from continuing operations
-27,392
-24,994
-14,901
-12,862
-5,802
-
Net income
-27,392
-24,994
-14,901
-12,862
-5,802
-
Net income available to common shareholders
-27,392
-24,994
-14,901
-12,862
-5,802
-
Basic EPS
-0.56
-
-0.42
-0.69
-0.20
-0.30
Diluted EPS
-0.56
-
-0.42
-0.69
-0.20
-0.30
Basic average shares
35,896
-
35,822
18,771
28,608
24,428
Diluted average shares
35,896
-
35,822
18,771
28,608
24,428